Company profile

The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited

The Biologicals and Vaccines Institute of Southern Africa Proprietary Limited, trading as The Biovac Institute, is a South African biopharmaceutical company based in Pinelands, Cape Town, South Africa. Established in 2003 as a public-private partnership between the South African government and a private consortium, Biovac was created to rebuild South Africa's human vaccine manufacturing capacity following the cessation of vaccine production at the State Vaccine Institute. The company is involved in vaccine development and manufacturing, including upstream and downstream processing, formulation, fill-and-finish manufacturing, labelling and packaging, quality control, distribution and cold-chain logistics. It has entered into technology-transfer partnerships and agreements with international vaccine manufacturers, including Sanofi, Pfizer, EuBiologics, and Biological E. Biovac supplies vaccines in South Africa and other Southern African markets, including Angola, Botswana, Eswatini, Lesotho, Mozambique, and Namibia.

Sector
Healthcare / Biotechnology, Pharmaceuticals
Markets
Namibia, Mozambique, Lesotho, Eswatini, Botswana, South Africa, Angola
Founded
2003
Ownership
Private
Stage
Corporate
Capital raised
$22m
Employees
500+
Business model
B2B Manufacturing

Products and services

Vaccines, Biologicals, Paediatric Vaccines

Transactions

Source: Partner Researchers.